Table 1.
Macrophage EVs | Neutrophil EVs | Platelet EVs, | Hepatocyte‐ASGR1+ EVs | Hepatocyte‐CYP2E1+ EVs | ||||||
---|---|---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | r | P | |
NAS (n = 36) | 0.554 | <0.001 | 0.511 | 0.001 | 0.406 | 0.014 | 0.432 | 0.024 | 0.428 | 0.012 |
Fat fraction (%) (n = 24) | 0.158 | 0.405 | 0.622 | <0.001 | 0.608 | <0.001 | 0.266 | 0.163 | 0.100 | 0.997 |
Steatosis grade (n = 36) | 0.364 | 0.029 | 0.197 | 0.249 | 0.206 | 0.228 | 0.486 | 0.032 | 0.525 | 0.013 |
Fibrosis stage (n = 36) | 0.577 | <0.001 | 0.597 | <0.001 | 0.518 | 0.001 | 0.502 | 0.002 | 0.511 | 0.003 |
Lobular inflammation (n = 36) | 0.415 | 0.012 | 0.341 | 0.042 | 0.205 | 0.231 | 0.463 | 0.010 | 0.425 | 0.016 |
Ballooning (n = 36) | 0.502 | 0.002 | 0.650 | <0.001 | 0.537 | 0.001 | 0.324 | 0.047 | 0.398 | 0.038 |